Results 171 to 180 of about 149,549 (197)

Intralesional immunotherapy for multiple recalcitrant plantar warts: Candida antigen is superior to intralesional purified protein derivative

Dermatologic Therapy, 2022
Treatment of recalcitrant plantar warts represent a highly challenging issue for both patients and physicians. Candida antigen and purified protein derivative (PPD) have shown promising efficacy in the treatment of warts, however no previous studies have compared both antigens for recalcitrant plantar warts.
Ahmad Nofal, Lamiaa Adel, Manal Fawzy, Basma M. Elkholy   +3 more
openaire   +2 more sources

Intralesional immunotherapy for the treatment of warts: A network meta-analysis

Journal of the American Academy of Dermatology, 2019
Without clear evidence, selecting among the existing immunotherapeutic options for warts remains challenging.Through network meta-analyses, we aimed to evaluate the comparative efficacy of different intralesional immunotherapeutic modalities.We included randomized controlled trials comparing intralesional immunotherapeutic modalities to cryotherapy ...
Samar, Salman, Mohamed Shehata, Ahmed, Ahmed Mohamed, Ibrahim, Omar Mohamed, Mattar, Hassan, El-Shirbiny, Sameh, Sarsik, Ahmed M, Afifi, Ruba Marwan, Anis, Nadim Aiman, Yakoub Agha, Abdelrahman Ibrahim, Abushouk   +9 more
openaire   +2 more sources

Successful treatment of doughnut warts with intralesional Candida antigen immunotherapy

Journal of Cosmetic Dermatology, 2020
AbstractBackgroundDoughnut warts, also called ring or annular warts, are a distinctive type of warts with central clearing and annular recurrence. There are very few studies illustrating this uncommon phenomenon and its treatment.AimsTo present 15 cases of doughnut warts and evaluate the efficacy and safety of Candida antigen intralesional ...
Ahmad Nofal, Ibrahim Fouda, Hany Aboelwafa, Mohamed M. Fawzy   +3 more
openaire   +2 more sources

Current and emerging intralesional immunotherapies in cutaneous oncology

Journal of the American Academy of Dermatology
Immunotherapies have revolutionized the management of advanced cutaneous malignancies. However, some patients fail to respond to these therapies, others are ineligible because of comorbidities, and a minority of patients experience treatment-limiting systemic immune-related adverse events.
Carolyn M, Stull, Denise, Clark, Tayler, Parker, Munir H, Idriss, Vishal A, Patel, Michael R, Migden   +5 more
openaire   +2 more sources

Efficacy of intralesional immunotherapy for the treatment of warts: A review of the literature

Dermatologic Therapy, 2016
Mohammed Alsaidan, Preetha Kamath, Keyvan Nouri   +2 more
exaly   +2 more sources

Long Term Protection in Bladder Cancer Following Intralesional Immunotherapy

Journal of Urology, 1984
Despite effective treatment of existing tumors, patients with bladder cancer remain at risk of developing new tumors. Effective immunotherapy may lower that risk. To test this hypothesis, mice that had survived transitional cell carcinoma (MBT2) transplantation with the aid of bacillus Calmette-Guerin immunotherapy were randomized and tested for long ...
D F, Reichert, D L, Lamm
openaire   +2 more sources

Administration and Handling of Talimogene Laherparepvec: An Intralesional Oncolytic Immunotherapy for Melanoma

Oncology Nursing Forum, 2016
To describe the administration and handling requirements of oncolytic viruses in the context of talimogene laherparepvec (Imlygic™), a first-in-class oncolytic immunotherapy.
.Study procedures employed in clinical trials, in particular the OPTiM study.
.Evaluation of nursing considerations for administration of talimogene laherparepvec.
Brianna, Hoffner, Gail M, Iodice, Eduard, Gasal   +2 more
openaire   +2 more sources

Efficacy of MMR Vaccine as Intralesional Immunotherapy in Viral Warts

Journal of Dermatology Research Reviews & Reports, 2021
Background: Warts are common in humans and account for 8% of visits to dermatologists. There are many destructive therapies available for the treatment of common warts, and no single treatment has yet proven 100% effective.Material and Method: In this hospital-based prospective study, a total of 100 patients with viral warts excluding genital warts ...
openaire   +1 more source

Induced regression of bovine papillomas by intralesional immunotherapy.

Therapeutic immunology, 1995
It has long been assumed that papilloma regression is mediated by immunological mechanisms which are probably cellular in nature. The potentiation of these responses may alter the course of papilloma progression. Certain strains of the bacterium Corynebacterium parvum (Propionibacterium acnes) have been shown to augment cellular immune mechanisms by ...
H, Hall, C, Teuscher, P, Urie, B, Boden, R, Robison   +4 more
openaire   +1 more source

Immunotherapy of bladder cancer with intralesional injection with BCG.

Journal of experimental pathology, 1988
Immunotherapy of bladder cancer with non specific immunostimulants, such as bacillus Calmette Guerin (BCG), has been shown to significantly reduce tumor recurrences, and, when applied through intravesical BCG instillation to induce the regression of some established tumors, including carcinomas "in situ" and even some invasive tumors.
P, Calsini, G, Scapicchi, O, Gazzarini, F, Melone, A, Aulisi, G, Pellegrini, N, Fabris, M, Provinciali   +7 more
openaire   +1 more source